Mavoglurant reduces cocaine use in patients with cocaine use disorder in a phase 2 clinical trial. - Gomez-Mancilla B; Dürsteler KM; Vogel M; Herdener M; Torrens M; Gálvez BP; Gual A; Corral RM; Kuper EI; Mosca DL; Dumitras S; Pezous N; et al. (Science translational medicine, 2025)